The stock has lost 7.3% while the S&P 500 ... On Friday, May 23, UBS analyst AJ Rice reaffirmed a “Buy” rating on The Cigna Group (NYSE:CI) with a price target of $390. Rice shared his views ...

RBC Capital has once again stamped an "Outperform" rating on The Cigna Group, signaling steady analyst confidence. The price ...

The Cigna Group CI, a longstanding global health company, continues to offer a variety of health solutions and insurance ...

Citi initiated coverage of Aspen Insurance Holdings (AHL) with a Buy rating on Monday based on the insurer's recently ...

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated ...

Citi analysts reiterated a Buy rating on Gilead Sciences, Inc. (NASDAQ:GILD) stock and maintained a $125 price target. The ...

A pair of new companies are being launched to tackle high drug costs, the latest sign of employer frustration with the middlemen, known as PBMs, whose job it is to keep down the spending. The cost ...

Martin has a “buy” rating and $145 price target for RDDT stock, which closed at $109.03 on May 29. Another one of the highest-ranked analysts in the WallStreetZen database is Wedbush analyst ...

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

Cigna’s first-quarter report shows strong numbers, but Barclays warns the road ahead could get rocky. Barclays highlights ...